Cargando…
Characterization of Pseudomonas aeruginosa Bacteriophage L5 Which Requires Type IV Pili for Infection
Pseudomonas aeruginosa is a common opportunistic human pathogen. With the emergence of multidrug-resistant (MDR) clinical infection of P. aeruginosa, phage therapy has received renewed attention in treating P. aeruginosa infections. Moreover, a detailed understanding of the host receptor of lytic ph...
Autores principales: | Yang, Lan, Zhang, Tingting, Li, Linlin, Zheng, Chao, Tan, Demeng, Wu, Nannan, Wang, Mingyang, Zhu, Tongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284122/ https://www.ncbi.nlm.nih.gov/pubmed/35847060 http://dx.doi.org/10.3389/fmicb.2022.907958 |
Ejemplares similares
-
A Filamentous Bacteriophage Protein Inhibits Type IV Pili To Prevent Superinfection of Pseudomonas aeruginosa
por: Schmidt, Amelia K., et al.
Publicado: (2022) -
Complete Genome Sequence of Pseudomonas aeruginosa Podophage MPK7, Which Requires Type IV Pili for Infection
por: Bae, Hee-Won, et al.
Publicado: (2013) -
Nanoscale Adhesion Forces of Pseudomonas aeruginosa Type IV Pili
por: Beaussart, Audrey, et al.
Publicado: (2014) -
First‐in‐human application of double‐stranded RNA bacteriophage in the treatment of pulmonary Pseudomonas aeruginosa infection
por: Li, Linlin, et al.
Publicado: (2023) -
Pseudomonas aeruginosa distinguishes surfaces by stiffness using retraction of type IV pili
por: Koch, Matthias D., et al.
Publicado: (2022)